Most Recent
Construction PRO
Tahmoor Coal liquidators lose appeal in royalties spat with Glencore
The liquidators of GFG Alliance's Tahmoor Coal have lost their appeal of a decision over a royalties deed in favour of former owner Glencore.
Appeals likely in drawn-out Coles, Woolworths overtime cases
Supermarket giants Coles and Woolworths, which are facing hundreds of millions of dollars in wage remediation costs after a landmark ruling, are likely to appeal once declarations are made in four drawn-out court cases.
Sydney litigation partner joins Ashurst Perkins Coie board
Sydney litigation partner Nicholas Mavrakis has been appointed to the Ashurst Perkins Coie board, just months after the firm finalised its merger with US firm Perkins Coie.
Fight looms over Sydney Uni academics’ defences in ‘antisemitic’ case
A date has been set for a potential fight over the defences of two University of Sydney academics in racial discrimination cases that accuse them of making antisemitic statements.
IAG finalises settlement in $2.8B Credit Suisse case over Greensill
Insurance Australia Group said Friday it had settled the $2.8 billion claims of Credit Suisse over the collapse of supply chain financier Greensill Capital.
Trial set in White Oak’s Greensill case, as IAG firms up Credit Suisse pact
A judge has set down the start of trial in Greensill investor White Oak's case against Insurance Australia Group, as the insurer finalises its settlement with Credit Suisse and UBS over the collapse of the supply chain funder.
Appeal tossed in postgrads class action against University of Sydney
The Full Federal Court has rejected an appeal by the applicant in a class action on behalf of post graduate students who claims he was underpaid by the University of Sydney.
Full Court tosses Plus500’s bid to stay class action over arbitration clause
The Full Court has rejected trading platform Plus500's bid to stay a class action by investors who lost money on highly leveraged contracts for difference in light of an arbitration clause in its terms and conditions, upholding a finding that the clause was an unfair contract term.
Pfizer loses patent case over Enbrel generic
Pfizer has lost a patent infringement lawsuit against Samsung Bioepis over the generic version of its blockbuster autoimmune drug Enbrel, with a judge finding all but one of the patent's claims is invalid. 
Arrotex can’t back up iron supplement claims, lawsuit alleges
The maker of Maltofer iron supplements is suing Arrotex over ads that claim its Ferro-grad C iron supplement is faster acting and reduces the risk of constipation.